Obstetrics/gynecology
Obstetrics
Dysmenorrhea

Dysmenorrhea

Introduction

Dysmenorrhea, a common gynecological condition, is crucial for Canadian medical students preparing for the MCCQE1 exam. This comprehensive guide covers key aspects of dysmenorrhea, focusing on Canadian healthcare perspectives and MCCQE1 exam preparation.

🇨🇦

This guide is tailored for the Canadian healthcare system and MCCQE1 exam. Pay attention to Canadian-specific guidelines and practices throughout.

Definition and Classification

Dysmenorrhea refers to painful menstruation. It is classified into two types:

Painful menses in the absence of pelvic pathology

Epidemiology in Canada

  • Prevalence: Affects approximately 60-90% of Canadian women
  • Age: Most common in adolescents and young adults
  • Impact: Leading cause of short-term school and work absenteeism among Canadian women
💡

For the MCCQE1, remember that dysmenorrhea significantly impacts the quality of life and productivity of Canadian women, making it an important public health concern.

Pathophysiology

Primary Dysmenorrhea

  1. Prostaglandin Theory: Excess production of prostaglandins (particularly PGF2α) in the endometrium
  2. Vasoconstriction: Leads to uterine ischemia
  3. Increased Uterine Contractility: Results in pain

Secondary Dysmenorrhea

Caused by various underlying conditions, including:

  • Endometriosis
  • Adenomyosis
  • Fibroids
  • Pelvic inflammatory disease (PID)

Clinical Presentation

History

  • Onset of pain (typically with menarche for primary dysmenorrhea)
  • Timing of pain (usually starts with menses)
  • Duration and severity of pain
  • Associated symptoms (nausea, vomiting, diarrhea)

Physical Examination

  • Generally normal in primary dysmenorrhea
  • May reveal tenderness or masses in secondary dysmenorrhea

Red Flags

  • Severe pain unresponsive to NSAIDs
  • Pain occurring outside of menses
  • Abnormal uterine bleeding

Differential Diagnosis

ConditionKey Features
EndometriosisChronic pelvic pain, dyspareunia, infertility
AdenomyosisHeavy menstrual bleeding, enlarged uterus
FibroidsMenorrhagia, pelvic pressure
PIDFever, cervical motion tenderness, vaginal discharge

Diagnostic Approach

Step 1: Detailed History and Physical Examination

Step 2: Laboratory Tests

  • Complete blood count (CBC)
  • Sexually transmitted infection (STI) screening if PID suspected

Step 3: Imaging

  • Transvaginal ultrasound (first-line imaging)
  • MRI (for complex cases or suspected adenomyosis)

Step 4: Laparoscopy

  • Gold standard for diagnosing endometriosis

Management

Non-pharmacological Interventions

  • Heat therapy
  • Exercise
  • Dietary changes (reducing caffeine, alcohol, and fatty foods)
  • Stress reduction techniques

Pharmacological Treatment

  1. First-line: NSAIDs (e.g., ibuprofen, naproxen)
  2. Second-line: Combined oral contraceptives (COCs)
  3. Third-line:
    • Progestin-only contraceptives
    • GnRH agonists (for severe cases)

Surgical Interventions

  • Reserved for secondary dysmenorrhea
  • Depends on underlying pathology (e.g., laparoscopic excision for endometriosis)

Canadian Guidelines

The Society of Obstetricians and Gynaecologists of Canada (SOGC) provides guidelines for managing dysmenorrhea:

  1. NSAIDs are the first-line treatment for primary dysmenorrhea
  2. COCs are recommended for women desiring contraception
  3. Laparoscopy is not routinely recommended for primary dysmenorrhea without suspicious findings
🇨🇦

MCCQE1 candidates should be familiar with SOGC guidelines, as they reflect Canadian standards of care and may be featured in exam questions.

Key Points to Remember for MCCQE1

  • Differentiate between primary and secondary dysmenorrhea
  • Recognize red flags suggesting secondary causes
  • Understand the prostaglandin theory in primary dysmenorrhea
  • Know the first-line treatments (NSAIDs and COCs)
  • Be aware of the impact of dysmenorrhea on Canadian women's quality of life
  • Familiarize yourself with SOGC guidelines for management

Sample Question

Question

A 17-year-old female presents with severe menstrual cramps that started shortly after menarche at age 13. The pain begins with menses, lasts 2-3 days, and is partially relieved by over-the-counter ibuprofen. She has no significant medical history and is not sexually active. Physical examination is unremarkable. Which one of the following is the most appropriate next step in management?

  • A. Prescribe combined oral contraceptives
  • B. Order transvaginal ultrasound
  • C. Recommend laparoscopy
  • D. Increase ibuprofen dosage
  • E. Prescribe GnRH agonist

Explanation

The correct answer is:

  • D. Increase ibuprofen dosage

Explanation: This case presents a typical picture of primary dysmenorrhea. The patient's age, onset of pain with menarche, timing of pain with menses, and normal physical examination are all consistent with primary dysmenorrhea. According to Canadian guidelines (SOGC), NSAIDs are the first-line treatment for primary dysmenorrhea. Since the patient reports partial relief with over-the-counter ibuprofen, the most appropriate next step is to optimize the NSAID dosage before moving to other treatments.

  • A is incorrect because while COCs are an effective treatment, they are typically considered second-line after optimizing NSAID therapy.
  • B is incorrect because imaging is not routinely recommended for typical primary dysmenorrhea without suspicious findings.
  • C is incorrect as laparoscopy is not indicated for primary dysmenorrhea and is reserved for cases where secondary causes are suspected.
  • E is incorrect because GnRH agonists are used for severe cases or secondary dysmenorrhea and would be inappropriate as a next step in this case.

This question tests the candidate's knowledge of the Canadian approach to managing primary dysmenorrhea, emphasizing the importance of following a stepwise approach in treatment.

References

  1. Society of Obstetricians and Gynaecologists of Canada. (2017). Primary Dysmenorrhea Consensus Guideline. Journal of Obstetrics and Gynaecology Canada, 39(7), 585-595. https://www.jogc.com/article/S1701-2163(17)30160-6/fulltext (opens in a new tab)

  2. Burnett, M., & Lemyre, M. (2017). No. 345-Primary Dysmenorrhea Consensus Guideline. Journal of Obstetrics and Gynaecology Canada, 39(7), 585-595. https://doi.org/10.1016/j.jogc.2016.12.023 (opens in a new tab)

  3. Lefebvre, G., Pinsonneault, O., Antao, V., Black, A., Burnett, M., Feldman, K., ... & Robert, M. (2005). Primary dysmenorrhea consensus guideline. Journal of Obstetrics and Gynaecology Canada, 27(12), 1117-1130. https://pubmed.ncbi.nlm.nih.gov/16524531/ (opens in a new tab)

  4. Osayande, A. S., & Mehulic, S. (2014). Diagnosis and initial management of dysmenorrhea. American family physician, 89(5), 341-346. https://www.aafp.org/pubs/afp/issues/2014/0301/p341.html (opens in a new tab)

  5. Armour, M., Parry, K., Al-Dabbas, M. A., Curry, C., Holmes, K., MacMillan, F., ... & Smith, C. A. (2019). Self-care strategies and sources of knowledge on menstruation in 12,526 young women with dysmenorrhea: A systematic review and meta-analysis. PloS one, 14(7), e0220103. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0220103 (opens in a new tab)